Introduction
Chinese medicine preparations (CMPs) have been widely used in clinics for thousands of years and have made great contributions to human health. Conventionally, CMPs were usually used in the form of decoction, which was troublesome for preparation and carrying. 1 not be ,75% according to the ChP. 6 The pharmaceutical process of PNS immediate release tablet is complex and involves several unit operations, which are mixing, wet granulation, milling, drying, blending, and tableting. Currently, the adjustment and control of the manufacturing process of PNS immediate release tablet is performed mainly based on experience. And the mechanical properties and release behavior of the product are at high risk of suffering from batch-to-batch variability. Therefore, there is an urgent need to investigate the relationship between the manipulated variables and the critical quality attributes (CQAs) of the PNS immediate release tablet to improve the process performance and consistently produce products with predefined quality.
Recently, quality by design (QbD) principles for pharmaceutical development are strongly encouraged by the International Conference on Harmonization and the US Food and Drug Administration. 8 QbD is a systematic approach to the development that begins with predefined objectives and emphasizes product and process understandings and process control, based on sound science and quality risk management. The objective of QbD is the achievement of a scientific understanding of how input materials and process parameters affect the product quality. Generally, a pharmaceutical process is considered to be well understood when 1) all critical sources of variability are identified and explained, 2) the variability is managed by the process, and 3) the product quality can be accurately and reliably predicted. 9, 10 A variety of tools can be used to fulfill the aim of QbD and to improve the process understanding. [11] [12] [13] For example, by using the design of experiment, [14] [15] [16] specific process parameters or intermediate quality attributes are used to collect process information.
For a pharmaceutical process system including multiple unit operations, it is difficult to establish a deterministic model to describe the process comprehensively. Therefore, the process understanding is usually realized by the application of multivariate analysis (MVA) techniques to the legacy or experimental data. [17] [18] [19] In MVA methods, the low-dimensional latent variables space are usually designed to summarize the process variability captured by the high-dimensional independent variables or quality attributes space of the pharmaceutical process system. 9 For example, Soh et al 20 applied principle component analysis (PCA) and partial least squares (PLS) to understand the impacts of different grades of lactose and microcrystalline cellulose and process parameters on the granule and ribbon properties obtained in a roller compaction process. In the work of Maltesen et al, 21 PCA was used to identify the critical process parameters (CPPs) and to find correlations between the dependent and independent variables in the spray-drying of insulin. Polizzi and García-Muñoz 22 proposed a novel modeling method, namely weighted PLS, to predict the properties of a powder blend. Westerhuis and Conengracht 23 pioneered the application of multiblock partial least squares (MBPLS) 24 to improve the interpretability and understanding of a two-step process, including wet granulation and tableting. Tomba et al 25 proposed a procedure for the application of MBPLS to support the development of a continuous pharmaceutical process from earlier stage using an industrial case. Extensive multivariate modeling applications for process understanding and control are described in a number of studies. [26] [27] [28] [29] [30] [31] [32] [33] [34] In this study, multiple statistical modeling methods, such as PLS, orthogonal projection to latent structures (OPLS), and MBPLS, are used to improve the interpretability of the manufacturing line of PNS immediate release tablet. The CPPs, the CQAs of intermediate, and the critical process units (CPUs) are determined. The effects of process parameters and granule properties on CQAs of product are also explored. To the best of our knowledge, this is the first study that applies different latent variables modeling methods to gain process knowledge for the multiunit pharmaceutical process of Chinese herbal medicine tablets. The advantages and the limitations of different chemometric methods are also summarized in the present work.
Materials and methods Materials
PNS extracts (lot number ZL20150524) were purchased from Nanjing Zelang Pharmaceutical Co., Ltd (Nanjing, People's Republic of China 
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Design of experiment
Ten process parameters including mixing time, impeller rate, binder amount, granulation liquid addition rate (addition rate), chopper rate, granulation time, sieve, drying time, lubrication time, and minimal punch tip separation distance (MPTSD) from five operation units were chosen to perform the experimental design and three levels were designated for each process parameter. The L27 orthogonal experimental design is used and a total of 27 runs are conducted, as shown in Table 1 . The tensile strength (TS) of tablet and the in vitro dissolution of Notoginsenoside R1, Ginsenoside Rg1, Ginsenoside Re, Ginsenoside Rb1, and Ginsenoside Rd at 30 minutes (min) were identified as CQAs of the PNS immediate release tablet since the TS reflects the mechanical properties of tablets and the dissolution is related to the efficacy of the medicine.
Preparation of tablet
The formulation of PNS immediate release tablet consists of PNS extracts (33.5%, w/w), microcrystalline cellulose (60%, w/w), crospovidone (6%, w/w), and magnesium stearate (0.5%, w/w).
First, PNS extract powders, the microcrystalline cellulose, and the crospovidone were weighed; 67, 120, and 12 g, respectively. These powders were premixed in a high shear wet granulator with the volume of 2 L (SHK-4A; Xi'an Run Tian Pharmaceutical Machinery Co., Ltd, Xi'an, People's Republic of China), the volume fill of premixed powders was ~40%. Then, the mixed powders were granulated with 95% alcohol, which was added by a peristaltic pump. The wet granules were milled through a sieve manually and dried in a tray dryer (temperature at 80°C). After that, the dried granules were lubricated with 1 g magnesium stearate in a three-dimensional blender with 1 L volume (ZNW-10, Beijing Xing Shi Li He Technology Co., Ltd). Lastly, the final blend was compressed into tablets using a rotary tablet press (ZP10, Xing Shi Li He Technology Co., Ltd). The diameter of the convex unscored punches was 11 mm, and the target tablet weight was 0.44 g.
analytical methods

Density of granule
The bulk density (D b ) and the tapped density (D t ) of granules were measured in a 250 mL cylinder according to the method angle of repose of granule
The angle of repose (α) of granule was measured with the powder flow ability tester (Copley BEP2; Copley Scientific Limited, Nottingham, UK). The samples were poured through a vibrating metal funnel onto a platform until a stable and height-fixed heap was formed. The angle of repose was measured as the angle made by the inclined plane of the heap with the horizontal. Each batch of sample was tested in triplicate.
Moisture content of granule
The moisture content of granule was tested using the Sartorius MA35 instrument (Sartorius AG, Goettingen, Germany). The sample was placed on the pan and heated to 105°C. The percentage of moisture content was recorded until the weight was constant. Each sample batch was tested in triplicate.
Ts of tablet
The hardness of tablet was evaluated with the HC 97 instrument (Kraemer Elektronik GmbH, Darmstadt, Germany). The tablet diameter and thickness were measured by the digimatic indicator (ID-C112X/1012X; Mitutoyo Corporation, Kawaskai, Japan). With these obtained data, the tablet TS was calculated according to the equation described by Fell and Newton.
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where F refers to the hardness of tablet (N), d refers to tablet diameter (mm), and t refers to tablet thickness (mm). Each batch of the sample was tested 10 times.
Dissolution of tablet
The dissolution test was conducted by the basket method at 100 rpm in 500 mL of water at 37°C±0.1°C. 36 The dissolved APIs were assayed by the high performance liquid chromatography (HPLC) method, 38 which was briefly described as follows. A Waters Alliance e2695 system (Waters Corporation, Milford, MA, USA) coupled with a Zorbax SB-C18 column (4.6×250 mm, 5 μm) was used. The mobile phase consisted of water (A) and acetonitrile (B). The separation of samples was achieved using the gradient elution program as follows: 20% B at 0-20 min, 20%-47% B at 20-50 min. The flow rate was 1.0 mL/min and the temperature of column was kept at 23°C. Each batch of sample was measured in triplicate.
Multivariate statistical analysis
The details of theories on PLS, OPLS, and MBPLS methods are available in the Supplementary materials. Matlab 7.0 software (MathWorks, Natick, MA, USA) was used to construct PLS, OPLS, and MBPLS models. PLS Toolbox 2.1 (Eigenvector Research Inc., Manson, WA, USA) was used to perform the PLS regression. The MBPLS toolbox was downloaded from http://www.models.life.ku.dk/~courses/MBtoolbox/mbtmain.htm. The OPLS code was downloaded from http://www.mathworks.com/matlabcentral/fileexchange/47767-libpls-1-95-zip/content/libPLS_1.95/opls.m. Prior to the analysis, all data were unit variance scaled.
Results and discussion
Measurements of granule properties and tablet quality attributes
For the purpose of process modeling, the independent variables were systematically chosen to cover the whole area of the manufacturing line and several batches were tested according to the experimental design. In this study, 10 process parameters and eight intermediate product (ie, granules) properties were denoted as the independent variables ( Table 2 ). The TS and dissolution of Notoginsenoside R1, Ginsenoside Rg1, Ginsenoside Re, Ginsenoside Rb1, and Ginsenoside Rd at 30 min (ie, R1-DIS30, Rg1-DIS30, Re-DIS30, Rb1-DIS39, and Rd-DIS30) are designed to be response variables. The results of TS and dissolution test are listed in Table 3 , and the measurement results of granule properties are shown in Table S1 . The HPLC chromatograms of the PNS standard and the sample (eg, Batch 17) from the dissolution test are displayed in Figure 1 . The results clearly showed that the release behavior of tablets from different batches was sensitive to process variations. However, for tablets from the same batch, the dissolution of R1, Rg1, Re, Rb1, and Rd at 30 min were negatively correlated with TS as expectations. 
Pls regression model
The relationship between independent variables and response variables was first investigated by the PLS regression method. The diagnostics of the PLS model are reported in Table 4 . Four predicted components explaining 94.2% of the CQAs variations were optimized, and the predictive ability of the model was good (Q 2 Ycum =80.6%). Figure 2 shows the relationships between independent variables and response variables under the projected latent structures. The loading bar plots are displayed in Figure 3 . The loadings of PLS model indicated which process parameters or granule properties affected product quality and estimated their relative contribution to quality. 25, 30 The first of the four predictive components in the PLS regression model explained 61.9% of CQAs variations. Its loadings indicated that granules with lower density and smaller granule size resulted in faster tablet dissolving. 38 The MPTSD had a significant effect on the dissolution and it was positively correlated with dissolution. It indicated that a smaller MPTSD led to a harder tablet that dissolved at a slower rate. The second component explained 25.4% of variations. Its loadings indicated that the impeller rate and the MPTSD were negatively correlated with the TS and granules with lower density and smaller particle size could result in higher TS. As we know, the thickness has a significant effect on the TS of tablets. 36 Setting a smaller MPTSD resulted in tablets with smaller thickness and higher TS. Decreasing granule size increased the specific surface area of granule and inter granule electrostatic adsorption, which led to high TS. The impeller rate had effects on growth behavior of granules in wet granulation process. Higher impeller rate resulted in larger size granules, which decreased the tablet TS. The third component explained 5.0% of variances, and its loadings indicated that the binder amount also had slight impacts on the TS. This result suggested that granulation with more binder resulted in larger size granules, which decreased the tablet TS.
Although the PLS model was simple and useful to analyze the relationship between the input data and the response, there was a risk that the input data contained systematic variations, which was not correlated with the response.
OPls regression model
In order to gain more understanding about the pharmaceutical process, an OPLS model was used. The diagnostics of OPLS model are available in Table 4 . Both the fitness (R 2 Ycum =95.1%) and the predictive ability (Q 2 Ycum =82.6%) of the model were good. The first two predicted components were adequate enough to model the CQAs, and the additional two predicted components only explained 0.4% of variations. The third and fourth components were selected in the OPLS model in order to increase the predictive ability. The model revealed that a small fraction of independent variables variation (R 2 Xcum =33.0%) were sufficient to Table 4 , the amount of variance explained in response variables was relatively large in the first component of the OPLS model. The amount of explained variation in independent variables, R 2 Xcum , was relatively small. In addition, four orthogonal components explained 43.1% variances in the independent variables. This implied that orthogonal variation with regard to the response variables exists in the dependent variables.
The relationships between independent variables and responses under the projected latent structure for the OPLS model are shown in Figure S1 . Figure S2 
MBPls regression model
In PLS and OPLS models, all input variables were organized in one data block, which ignored the fact that the pharmaceutical process consisted of multiple units. Therefore, an MBPLS model was introduced. The independent variables are divided into six data blocks as seen in Table 2 . The MBPLS model was used to understand the intrablock and inter-block relations. Table 4 shows the diagnostics of the MBPLS model. Two components were sufficient to model the CQAs. The additional components were used to increase the performance of the model. Four components were used to build the model, explaining 94.2% of the CQAs variance. The predictive ability of the model was good (Q 2 Ycum =87.9%). Figure S3 displays the relationships between independent variables and responses for the MBPLS model. The bar plots of loadings of independent variables are reported in Figure S4A , whereas the bar plots of loadings of responses are reported in Figure S4B . The first component explaining 83.1% of the CQAs variations mainly described the correlations between the MPTSD and the CQAs. The MPTSD appeared to be positively related with the dissolution and negatively related with TS, which was consistent with the PLS or OPLS modeling results. The second component explaining 6.7% of the CQAs variations mainly described the relationships between the lubrication time and the TS. The loadings indicated that the lubrication time was negatively related with the TS. Before tableting, the dry granules were mixed with the magnesium stearate. As lubrication time was increased, the magnesium stearate was distributed uniformly on the surface of granules. The inter-granule cohesion strength might have decreased when granule was compressed into the tablet. Therefore, increasing the lubrication time may result in lower tablet TS.
In order to identify the critical independent variables, the variable importance in the projection (VIP) index could be calculated for each variable. The function of VIP is defined below. Figure 4 reports the VIP index of each variable in PLS, OPLS, and MBPLS models, respectively. Usually, a threshold equal to 1 was assigned to evaluate whether a variable was important in the prediction of CQAs. 40 In Figure 4A , MPTSD, D 10 , and D 50 are identified to be the most important variables in the PLS model, while other variables including the binder amount, the granule density, and D 90 were near the threshold. Figure 4B shows VIP indexes of variables in the OPLS model, and MPTSD and D 10 are identified to be significant in prediction of CQAs. D 50 was no longer significant in OPLS models. It indicated that the variability of D 50 of granules contributed less to the CQAs of the tablet. Both PLS and OPLS methods confirmed D 10 and MPTSD were key variables. Figure 4C shows that MPTSD was identified as the most important variable in the MBPLS model, and the lubrication time that was nonsignificant in PLS or OPLS model also contributed largely to the variability in CQAs. 
Notes:
The red line refers to the threshold value of ViP. span, the width of granule size distribution. Abbreviations: MPTsD, minimal punch tip separation distance; OPls, orthogonal projection to latent structures; Pls, partial least squares; D b , bulk density; D t , tapped density; D 10 , D 50 , and D 90 , particle size for 10%, 50%, and 90% of granules; hr, moisture content; α, angle of repose; MBPls, multiblock partial least squares; OPls, orthogonal projection to latent structures; Pls, partial least squares; ViP, variable importance in the projection. In the MBPLS model, the CPU in the manufacturing line could be identified by calculating the block importance in the projection (BIP) index. 41 A threshold equal to 1 was also used to assess whether a block was important to predict the CQAs. Figure 5 reports Table 2 . The results suggested that the tableting unit was the CPU determining the product CQAs.
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real time release testing prediction model for cQas
Based on the results obtained from the three latent variable models, real-time release testing (RTRT) for CQAs of the PNS immediate release tablet could be performed based on the prediction formula using parameters of not only "granule attribute" such as the D 10 of granules (A) but also "process parameters" such as the lubrication time (B) and the MPTSD (C) as shown below: were larger than 0.8, and it indicated the relationship between critical independent variables and the CQAs were well fitted using the ordinary least squares regression method. Process control strategies can also be performed by controlling the significant variables in the RTRT prediction models so that the desired quality of product will be achieved.
Conclusion
Traditionally, the quality control of Chinese herbal medicine preparations was mainly based on extensive end product testing and acceptance criteria due to inadequate understanding of the impacts of CMAs and CPPs on the drug product. And it was often time consuming to determine the source of variability when faulty product occurred. In this paper, with the help of PLS, OPLS, and MBPLS modeling methods, comprehensive process knowledge was gained from the process data. Identification of key process variables simplified the input-output relationships to control the product quality. Such enhanced QbD approaches could be applied not only in the pharmaceutical development stage to control the potential risk but also in the manufacturing stage to monitor and control CQAs with a high level of assurance. 
Supplementary materials Theories Partial least squares regression
Partial least squares regression applies to the two data blocks (eg, X and Y) regression problem, which uses X to construct a model of Y. 1 This leads to two equations:
here, T is the score matrix of X; P is the loading matrix of X; and E is the residual matrix of X. U is the score matrix of Y; Q is the loading matrix of Y; and F is the residual matrix of Y.
Orthogonal projection to latent structures regression
In application of partial least squares (PLS) model, there is a risk that systematic variation may reside in X, which is not linearly correlated with Y. In order to avoid this, orthogonal projection to latent structures regression is proposed. 2 Orthogonal projection to latent structures (OPLS) uses information in Y to decompose the X data into two parts. One part is linearly related to Y and the other is orthogonal to Y, as seen in the following equations:
here, T p denotes the correlated score matrix of X and P p denotes the correlated loading matrix of X. T o denotes the corresponding score matrix of Y-uncorrelated components and P o denotes the corresponding Y-uncorrelated loading matrix. Further details of the OPLS algorithm are described by Tyggy.
2,3
Multiblock partial least squares regression
Multiblock partial least squares regression is also an extension to the standard PLS. 4 The main difference between multiblock partial least squares (MBPLS) and PLS is that two or more data blocks (X 1 , X 2 , …, X k ) are used to model Y in MBPLS. 
Table S1
The results of granule properties measurements Two varieties of MBPLS algorithms had been reported in the literature. 6 One uses the block scores to calculate the loadings and residuals, 7 while the other uses the super scores. 8 The algorithm used in this paper was based on the later version due to the inferior prediction of the former version. 9 Two blocks (X 1 and X 2 ) are used here to illustrate the model:
here, T s refers to the super score matrix of X; P 1 refers to the loading matrix of X 1 ; P 2 refers to the loading matrix of X 2 ; E 1 refers to the residual matrix of X 1 ; and E 2 refers to the residual matrix of X 2 . , and D 90 , particle size for 10%, 50%, and 90% of granules; hr, moisture content; MPTsD, minimal punch tip separation distance; OPls, orthogonal projection to latent structures; span, the width of granule size distribution; MBPls, multiblock partial least squares; Ts, tensile strength.
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